Gout

A  randomized double-blind, placebo-controlled study of SEL-212 in patients with Gout Refractory to Conventional Therapy.

Study Information

Condition

Gout

Phase 3

Conquest Research needs volunteers for a randomized double-blind, placebo-controlled study of SEL-212 in patients with Gout Refractory to Conventional Therapy. You may qualify if you:

  • Are between the age of 18 and 65

  • Have a current diagnosis of Gout

  • Are experiencing gout flares

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

What To Expect

PATIENT RESOURCES & FAQ

Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

SEE MORE
A mature medical doctor smiling as some of his colleagues stand in the background

Register For A Study!

Register